Medi Globe
Medi Globe Group, headquartered in Germany, is a prominent player in the medical technology industry, specialising in innovative solutions for minimally invasive surgery. Founded in 2001, the company has established a strong presence across Europe and beyond, focusing on the development and distribution of high-quality medical devices and instruments. Medi Globe's core offerings include advanced endoscopic products and surgical instruments, designed to enhance precision and efficiency in surgical procedures. Their commitment to quality and innovation has positioned them as a trusted partner for healthcare professionals worldwide. With a reputation for excellence, Medi Globe continues to achieve significant milestones, solidifying its status as a leader in the medical technology sector.
DitchCarbon Score
How does Medi Globe's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medi Globe's score of 10 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medi Globe's reported carbon emissions
In 2023, Medi Globe reported a significant reduction in its carbon emissions, with total emissions amounting to approximately 613,000 kg CO2e. This marks a substantial decrease from 2022, when emissions were about 1,413,000 kg CO2e, and from 2021, which saw total emissions of around 1,483,000 kg CO2e. The emissions for 2023 were entirely from Scope 1, indicating direct emissions from owned or controlled sources, while Scope 2 and Scope 3 emissions were reported as zero. Despite the notable reduction in emissions, Medi Globe has not publicly disclosed specific reduction targets or commitments under the Science Based Targets initiative (SBTi) or any other climate pledges. The company’s focus appears to be on reducing its direct emissions, as evidenced by the significant drop in Scope 1 emissions over the past two years. Medi Globe's commitment to addressing climate change is reflected in its ongoing efforts to lower its carbon footprint, although further details on long-term strategies or additional climate initiatives are not available at this time.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 1,483,000 | 0,000,000 | 000,000 |
| Scope 2 | - | - | - |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medi Globe is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
